No Data
No Data
Itochu's operating profit for the first quarter increased by 13.9% to 190.5 billion yen.
Itochu (8001) announced its first quarter results for the March 2025 fiscal year, with revenue of 3.598918 trillion yen, a 7.5% increase compared to the same period of the previous year, while operating profit increased by 13.9% to 190.539 billion yen.
ASKA Pharmaceutical Holdings: Supplementary information for the fiscal Q1 financial statement for March 2025.
ASKA Pharmaceutical Holdings: Short message of Q1 financial results for March 2025 (consolidated, Japanese standard).
ASKA Pharmaceutical 1Q Net Y1.27B Vs Net Y1.43B
Ajinomoto, Itochu, Orix, and NYK (on the 5th).
※The above calendar is only a plan and may be subject to change due to company's convenience. --------------------------------------- August 5 (Monday) <1301> Kyokuyo <130A> VIS <1333> Maruha Nichiro <1787> Nakabo Tech <1826> Sataken <1898> Seikietokyu <1967> Yamato <2004> Showa Sangyo <2117>
List of conversion stocks (Part 3) [List of parabolic signal conversion stocks]
List of sell conversion stocks in the market Code, Company Name, Closing Price, SAR, TSE Prime 4553, Touwa Pharmaceutical, 2880, 3130 4658, Nihon Kuki, 982, 1029 4681, Resort Trust, 2438, 2533 4828, B EnG, 3975, 4200 4849, En Japan, 27
No Data